Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit) (Tweet2Quit)
Social Media Technology for Treating Tobacco Addiction
Sponsor: National Cancer Institute (NCI)
A PHASE2 clinical study on Smoking Cessation, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 14 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Dec 2024 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Apr 2023 — Jun 2023 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
▶ Show 9 earlier versions
-
Jun 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
-
Apr 2021 — Jun 2022 [monthly]
Active Not Recruiting PHASE2
Status: Completed → Active Not Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Completed PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Apr 2020 — Dec 2020 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Nov 2018 — Apr 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Stanford University
- University of California, Irvine
For direct contact, visit the study record on ClinicalTrials.gov .